SOLV · 8-K · 20260805PR000045
Segment Revenue Performance
Solventum Corp · 2026-08-05 · Importance 78 · Surprise 64 · No source text
Second-quarter MedSurg revenue increased $154 million to $1.372 billion, with operating income rising to $355 million from $210 million and operating margin expanding to 25.8% from 17.3%. Dental Solutions revenue grew $58 million to $396 million, while operating income increased to $131 million and margin rose to 33.0% from 28.5%. Health Information Systems revenue increased $15 million to $354 million, with operating income of $145 million and margin of 41.0%, compared with 35.5% in the prior-year quarter. Total reportable segment sales increased $227 million to $2.122 billion, while the prior-year $189 million Purification and Filtration contribution was eliminated after its September 2025 sale.
Key facts
- Advanced Wound Care net sales for Q2 2026: $537 million, reported growth 14.9%, currency impact 1.0%, constant currency 13.9%, Other 6.8%, organic growth 7.1% source
- Infection Prevention and Surgical Solutions net sales for Q2 2026: $836 million, reported growth 11.3%, currency impact 1.2%, constant currency 10.1%, organic growth 10.1% source
- Dental Solutions net sales for Q2 2026: $396 million, reported growth 17.0%, currency impact 1.8%, constant currency 15.2%, organic growth 15.2%; operating income $131 million with operating margin 33.0% source
- Total reportable segment net sales for Q2 2026: $2,122 million (Total reportable segment net sales vs prior year $1,895 million) source
- Health Information Systems net sales for Q2 2026: $354 million, reported growth 4.4%, currency impact 0.2%, constant currency 4.2%, Other (1.2)%, organic growth 5.4%; operating income $145 million with operating margin 41.0% source
- All Other net sales for Q2 2026: $87 million, reported growth 11.8%, currency impact 1.2%, constant currency 10.6%, organic growth 10.6%; operating income $19 million with operating margin 21.4% source
- MedSurg total net sales for Q2 2026: $1,372 million (combined Advanced Wound Care and Infection Prevention and Surgical Solutions) and MedSurg operating income $355 million with operating margin 25.8% source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +62.1% | MedSurg total net sales for Q2 2026: $1,372 million (combined Advanced Wound Care and Infection Prevention and Surgical Solutions) and… |
| revenue | positive | realized | +10.3% | Total reportable segment net sales for Q2 2026: $2,122 million (Total reportable segment net sales vs prior year $1,895 million) |
| revenue | positive | realized | +3.9% | Infection Prevention and Surgical Solutions net sales for Q2 2026: $836 million, reported growth 11.3%, currency impact 1.2%, constant… |
| revenue | positive | realized | +3.2% | Advanced Wound Care net sales for Q2 2026: $537 million, reported growth 14.9%, currency impact 1.0%, constant currency 13.9%, Other 6.8%,… |
| revenue | positive | realized | +2.6% | Dental Solutions net sales for Q2 2026: $396 million, reported growth 17.0%, currency impact 1.8%, constant currency 15.2%, organic growth… |
| revenue | positive | realized | +0.7% | Health Information Systems net sales for Q2 2026: $354 million, reported growth 4.4%, currency impact 0.2%, constant currency 4.2%, Other… |
| revenue | positive | realized | +0.4% | All Other net sales for Q2 2026: $87 million, reported growth 11.8%, currency impact 1.2%, constant currency 10.6%, organic growth 10.6%;… |
| operating_income | positive | realized | — | All Other net sales for Q2 2026: $87 million, reported growth 11.8%, currency impact 1.2%, constant currency 10.6%, organic growth 10.6%;… |
| operating_income | positive | realized | — | MedSurg total net sales for Q2 2026: $1,372 million (combined Advanced Wound Care and Infection Prevention and Surgical Solutions) and… |